Press release
Angina Pectoris Drugs Market Forecasting and Key Trends: Growth and Regional Insights for 2025-2034 | Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC
Angina Pectoris Drugs Market
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide angina pectoris drugs market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by type, drug class, route of administration, end users, and region in the study, which offers a comprehensive picture of the state of the market.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/angina-pectoris-drugs-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
Angina pectoris is a heart condition marked by the narrowing of coronary arteries, which results in decreased blood flow to the heart. Symptoms encompass chest pain, dizziness, tiredness, unease, nausea, breathlessness, and perspiration. Antianginal medications prevent, stop, or resolve episodes of angina pectoris. These medications assist in lowering oxygen requirements, enhancing oxygen supply to the myocardium, and blocking calcium channels and platelet clumping.
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ:
โข The rising inclination toward combination therapies is driving enhanced research and development in this field, which is anticipated to boost market growth throughout the projected period.
โข The growing trend of personalized medicine is influencing the angina pectoris drugs market by customizing therapies to match individual patient characteristics. The increasing comprehension of genetic and molecular elements affecting drug response is anticipated to enhance the need for personalized medications.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
As the market expands, competition is expected to increase with the involvement of numerous businesses.
Here are the top companies in the market:
โข Pfizer Inc.
โข AstraZeneca PLC
โข GlaxoSmithKline PLC
โข Novartis AG
โข Merck & Co., Inc.
โข Sanofi S.A.
โข Eli Lilly and Company
โข Bristol-Myers Squibb Company
โข Johnson & Johnson
โข Roche Holding AG
โข Boehringer Ingelheim GmbH
โข Abbott Laboratories
โข Amgen Inc.
โข Bayer AG
โข Takeda Pharmaceutical Company Limited
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/angina-pectoris-drugs-market/request-for-discount-pricing
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional analysis, North America had the largest share in the global market, mainly owing to its advanced healthcare system, elevated incidence of cardiovascular illnesses, and substantial funding in research and development.
Also, Asia Pacific is experiencing fast growth, propelled by enhanced healthcare accessibility, growing rates of cardiovascular diseases, and broadening economic progress.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
By Type Outlook (Revenue - USD Billion, 2020-2034)
โข Stable Angina
โข Unstable Angina
โข Others
By Drug Class Outlook (Revenue - USD Billion, 2020-2034)
โข Beta Blockers
โข Anticoagulants
โข Others
By Route of Administration Outlook (Revenue - USD Billion, 2020-2034)
โข Oral
โข Parenteral
โข Transdermal
โข Others
By End Users Outlook (Revenue - USD Billion, 2020-2034)
โข Hospitals
โข Homecare
โข Specialty Clinics
โข Others
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/angina-pectoris-drugs-market/inquire-before-buying
๐๐ง๐ ๐ข๐ง๐ ๐๐๐๐ญ๐จ๐ซ๐ข๐ฌ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:
โข Based on type, the stable angina segment dominates the angina pectoris drugs market due to its higher prevalence compared to unstable angina and others, driven by better management and treatment options for stable angina.
โข In terms of drug class, the beta blockers segment leads the market as the primary class of medication for angina pectoris, owing to their effectiveness in reducing heart workload and controlling symptoms.
โข Oral administration is the most commonly used route because of its convenience and effectiveness in delivering chronic angina therapies.
โข By end users, the hospitals segment holds the largest market share as they provide comprehensive care and advanced treatments for acute angina cases, compared to other settings such as homecare or specialty clinics.
โข North America is the dominating and the highest growing region, driven by advanced healthcare infrastructure and increasing awareness of cardiovascular health. However, Asia Pacific is showing rapid growth potential due to rising healthcare investments and an expanding patient base.
โข Key players in the angina pectoris drugs market include major pharmaceutical companies such as Pfizer Inc.; AstraZeneca PLC; GlaxoSmithKline PLC; Novartis AG; and Merck & Co., Inc.
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
Attention Deficit Hyperactivity Disorder Market
https://www.polarismarketresearch.com/industry-analysis/attention-deficit-hyperactivity-disorder-market
Ophthalmic Equipment Market
https://www.polarismarketresearch.com/industry-analysis/ophthalmic-equipment-market
Hypnotherapy Market
https://www.polarismarketresearch.com/industry-analysis/hypnotherapy-market
Pharmacovigilance Market
https://www.polarismarketresearch.com/industry-analysis/pharmacovigilance-market
Dental Service Organization Market
https://www.polarismarketresearch.com/industry-analysis/dental-service-organization-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angina Pectoris Drugs Market Forecasting and Key Trends: Growth and Regional Insights for 2025-2034 | Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC here
News-ID: 3778009 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Angina
Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pecto โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Angina Pectoris Drugs Market Size By 2025?
The market size for angina pectoris drugs has experienced consistent growth in the past few years. The market is projected to expand from $12.32 billion in 2024 to $12.88 billion in 2025, representing a compound annual growth rateโฆ
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem โฆ
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic anginaโฆ
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar โฆ
What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as aโฆ
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,โฆ
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the builtโฆ
Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview
The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow toโฆ
